Provider‐related barriers and enablers to the provision of hepatitis C treatment by General Practitioners in Scotland: A behaviour change analysis
Journal Article
Whiteley, D., Speakman, E., Elliott, L., Davidson, K., Hamilton, E., Jarvis, H., …Flowers, P. (2021)
Provider‐related barriers and enablers to the provision of hepatitis C treatment by General Practitioners in Scotland: A behaviour change analysis. Journal of Viral Hepatitis, 28(3), 528-537. https://doi.org/10.1111/jvh.13443
The ease of Direct Acting Antiviral (DAA) medications for hepatitis C virus (HCV) has provided an opportunity to decentralise HCV treatment into community settings. However, ...
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)
Journal Article
Hickman, M., Dillon, J. F., Elliott, L., De Angelis, D., Vickerman, P., Foster, G., …Hutchinson, S. J. (2019)
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol). BMJ Open, 9(9), https://doi.org/10.1136/bmjopen-2019-029538
Hepatitis C virus (HCV) is the second largest contributor to liver disease in the UK, with injecting drug use as the main risk factor among the estimated 200 000 people curren...
Hepatitis C in a new therapeutic era: Recontextualising the lived experience
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2017)
Hepatitis C in a new therapeutic era: Recontextualising the lived experience. Journal of Clinical Nursing, https://doi.org/10.1111/jocn.14083
Aims and Objectives
To explore the experience of adults living with hepatitis C in a new era of interferon-free treatment.
Background
Hepatitis C is a leading cause of morbidi...
Recontextualising the lived experience of hepatitis C and its treatment
Thesis
Whiteley, D. J. (2016)
Recontextualising the lived experience of hepatitis C and its treatment. (Thesis). Edinburgh Napier University. Retrieved from http://researchrepository.napier.ac.uk/Output/979740
BACKGROUND: Rapid advances in the treatment of the hepatitis C virus (HCV) have been witnessed in clinical practice over the last five years. Pharmacological developments have...
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis
Journal Article
Whiteley, D., Whittaker, A., Elliott, L., & Cunningham-Burley, S. (2016)
The lived experience of interferon-free treatments for hepatitis C: A thematic analysis. International Journal of Drug Policy, 38, 21-28. https://doi.org/10.1016/j.drugpo.2016.10.013
Background: International discourse concerning the evolution in hepatitis C virus (HCV) therapy has tended to focus on improving outcomes, shortened treatment length and reduc...
Why aren't we treating the treatable? An audit of all HIV/HCV co-infected individuals attending an HIV clinic
Presentation / Conference
Whiteley, D. (2011, April)
Why aren't we treating the treatable? An audit of all HIV/HCV co-infected individuals attending an HIV clinic. Poster presented at 17th Annual Conference of the British HIV Association (BHIVA
Poster abstracts.